Oncology

Latest News

NSCLC | Image: Lung Cancer Foundation of America
Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC

April 28th 2025

Results could give patients with HER2-mutated non–small cell lung cancer (NSCLC) an oral therapy option.

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com
Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

April 23rd 2025

Diabetes monitoring | Image credit: abidika - stock.adobe.com
New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

April 23rd 2025

Vitamin D | Image credit: Galina Zhigalova - stock.adobe.com
Vitamin D’s Potential Role in Colorectal Cancer Prevention, Immune Health

April 23rd 2025

The study highlighted symptom patterns in the short-term preceding ED visits and unplanned hospitalizations using a previously validated natural language processing a pipeline. | Image credit: Tyler Olson - stock.adobe.com
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities

April 22nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

NCCN Annual Virtual Conference
March 19th 2021

Benefits and Challenges of ePRO Implementation in Oncology

Rose McNulty
During a session at the National Comprehensive Cancer Network (NCCN) annual virtual conference, the payer perspective and physician experiences with PRO systems in both the community and academic medical center settings took center stage.
NCCN
March 18th 2021

White, Brown Bagging of Therapies Creates Extra Steps for Oncology Practices

Mary Caffrey
Pharmacists from the Cleveland Clinic discuss the impact of payer dispensing requirements, known as white bagging and brown bagging, on oncology practices and on patients.
Cancer Survivors Returning to Work: Barriers and Interventions
March 18th 2021

Cancer Survivors Returning to Work: Barriers and Interventions

Rose McNulty
Amye J. Tevaarwerk, MD, director of the Survivorship Program at the University of Wisconsin Carbone Cancer Center, discussed the impact that cancer diagnosis and treatment can have on survivors when it comes to work.
This Week in Managed Care: March 12, 2021
March 12th 2021

This Week in Managed Care: March 12, 2021

This week, the top news in managed care included CDC guidance on safe activities for fully vaccinated individuals; American Rescue Plan signed into law; new lung cancer screening criteria expand eligibility.
Lung Cancer
March 10th 2021

New USPSTF Lung Cancer Screening Criteria Cover More High-Risk Patients

Rose McNulty
Updated lung cancer screening recommendations from the U.S. Preventive Services Task Force include 2 changes that will nearly double the number of people eligible for screening.
Cancer Care From the COVID-19 Front Lines: “Flying by the Seat of Our Pants”
March 7th 2021

Cancer Care From the COVID-19 Front Lines: “Flying by the Seat of Our Pants”

Mary Caffrey
A panel at the Association of Community Cancer Centers discusses lessons from the year of COVID-19.
Electronic Patient Monitoring Demonstration
March 3rd 2021

Integrating Remote Symptom Management With ePROs in Cancer Care

Rose McNulty
A presentation at the ACCC 47th Annual Meeting & Cancer Center Business Summit gave virtual attendees an overview of research on PROs and how RSM can be incorporated into an oncology practice.
breast cancer
March 2nd 2021

Athenex Receives CRL on Oral Paclitaxel Plus Encequidar for Treatment of Metastatic Breast Cancer

Mary Caffrey
FDA's action marks an abrupt change of course from the Priority Review granted September 2020.
Kavita Patel
March 1st 2021

Kavita Patel: Drug Pricing, Care Access Priorities in Federal Health Care Policy

Rose McNulty
Kavita Patel, MD, MS, FACP, a fellow at the Brookings Institution Center for Health Policy, touched on key topics in health care at the ACCC 47th Annual Meeting and Cancer Center Business Summit.
Researcher in Laboratory
February 24th 2021

Oncolytic Virus, CAR T Combination Preclinical Study Shows Activity in Solid Tumors

Rose McNulty
Loading chimeric antigen receptor (CAR) T-cells with the oncolytic virus pelareorep improved their efficacy in solid tumor mouse models in a preclinical study presented at the CAR-TCR Summit Europe 2021.
Older Woman Speaking With Doctor
February 24th 2021

Real-World Outcomes Contrast Cancer Clinical Trial Results in Medicare Patients

Rose McNulty
Pivotal cancer clinical trial data may lack generalizability in older adults with Medicare, a study published online today in JAMA Network Open found.
FDA Approves Libtayo Monotherapy for First-Line Advanced NSCLC With PD-L1 Expression
February 22nd 2021

FDA Approves Cemiplimab for First-Line Advanced NSCLC With PD-L1 Expression

Rose McNulty
The PD-1 inhibitor cemiplimab-rwlc, sold as Libtayo, was FDA approved as a monotherapy for patients with first-line advanced non–small cell lung cancer (NSCLC) with PD-L1 expression of at least 50%.
Donald M. Berwick, MD, MPP
February 18th 2021

Use of COTA Nodal Address Highlights Variance in Cancer Care Cost: An Interview With Donald M. Berwick, MD, MPP

Mary Caffrey
Donald M. Berwick, MD, MPP, the former CMS administrator who is president emeritus and senior fellow at the Institute for Healthcare Improvement, discusses cost variation in cancer care found through the digital classification system the COTA Nodal Address.
Anne Hubbard, MBA
February 18th 2021

Radiation Oncology’s Role in the Next Chapter of Payment Reform

Anne Hubbard, MBA
An ideal alternative payment model would reward radiation oncologists for participation in a value-based payment arrangement that grants them the freedom to make care delivery decisions based on patient needs and in accordance with clinical guidelines, says ASTRO's Anne Hubbard, MBA.
Cosela Approved for Protection Against Myelosuppression From SCLC Treatment
February 17th 2021

Cosela Approved for Protection Against Myelosuppression From SCLC Treatment

Maggie L. Shaw
The cyclin-dependent kinase 4/6 inhibitor trilaciclib (Cosela) is the first in its class to receive FDA approval as a protective agent against bone marrow loss from treatment for small cell lung cancer (SCLC).
Amy Ellis, Northwest Medical Specialties
February 17th 2021

Amy Ellis: There Was a Big Shift to Telemedicine in Cancer Care Delivery

With the onset of the pandemic, the increased use of telemedicine has been the biggest change to how cancer care is being delivered; however, whether telemedicine is here to stay depends on the regulators and payers, said Amy Ellis, chief quality officer at Northwest Medical Specialties.
Flying the Plane While You Build It
February 16th 2021

Flying the Plane While You Build It

Joseph Alvarnas, MD
In this issue of Evidence-Based Oncology™ we see a foreshadowing of what the future of cancer care innovation could look like and how we may learn to move forward, safely, at an ever-accelerating pace.
DNA Analysis
February 10th 2021

Liquid Biopsy Demonstrates Clinical Utility in Advanced Prostate Cancer

Rose McNulty
A new study assessed the genomic alterations identified by ctDNA analysis compared with tissue-based comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.
Amy Ellis, Northwest Medical Specialties
February 3rd 2021

Amy Ellis on the Benefits of ePROs in Cancer Care

Electronic patient-reported outcomes (ePROs) tools can benefit patients by keeping them on treatment longer, and the pandemic has likely accelerated how many practices move to using ePROs, said Amy Ellis, chief quality officer at Northwest Medical Specialties.
Amy Ellis, Northwest Medical Specialties
January 22nd 2021

Amy Ellis Discusses Setting Up an ePRO Tool at a Community Cancer Center

Setting up a new tool to capture electronic patient-reported outcomes (ePROs) requires a lot of prep work to ensure patients are comfortable and ready to use the tool, said Amy Ellis, chief quality officer at Northwest Medical Specialties.
Sibel Blau, MD, Northwest Medical Specialties, Quality Cancer Care Alliance
January 18th 2021

Dr Sibel Blau Discusses Adapting to Telehealth in Oncology and Future Issues

Adapting to telehealth was not difficult, but practice transformation around telehealth has been more difficult, and there remains the future uncertainty around continued reimbursement, said Sibel Blau, MD, of Northwest Medical Specialties and Quality Cancer Care Alliance.
Sibel Blau, MD, Northwest Medical Specialties, Quality Cancer Care Alliance
January 12th 2021

Dr Sibel Blau Discusses the Impact of Delayed Cancer Diagnoses on Community Cancer Practices

Telehealth is helpful, but it is not enough to make up for the delay in cancer diagnoses occurring as a result of the pandemic, said Sibel Blau, MD, of Northwest Medical Specialties and Quality Cancer Care Alliance.
Here's your email
January 8th 2021

What We’re Reading: AHA Wants Faster Vaccine Rollout; Cancer Effect on Hearts; Teen Opioid Access

AJMC Staff
The American Hospital Association (AHA) asks HHS Secretary Alex Azar to expedite the rollout of coronavirus disease 2019 vaccines; CDC data show accelerated cardiac aging among cancer survivors; a study examines new targets for reducing adolescent access to opioids.
Basit Chaudhry, MD, PhD, Tuple Health
January 6th 2021

Dr Basit Chaudhry Expects CMS to Take Feedback From the Field to Improve OCF

Feedback from the field is incredibly important when participating in new payment models like the Oncology Care Model, said Basit Chaudhry, MD, PhD, founder of Tuple Health.
The Top 5 Most-Read Oncology Stories of 2020
December 28th 2020

The Top 5 Most-Read Oncology Stories of 2020

Rose McNulty
Our 5 most-read oncology stories and most-watched videos this year highlighted cancer care policy, diversity, and the growing practice of remote cancer care.
Mike Fazio, Archway Health
December 26th 2020

Mike Fazio on Choosing Between Oncology Care First or Another Oncology APM

Practices deciding whether to join Oncology Care First or another oncology alternative payment model (APM) will need a clear understanding of how big of a transformation they’ll need to make to their practice, said Mike Fazio.
Radiopharmaceuticals Are Showing Promise as the Next Generation of Cancer Treatment
December 24th 2020

Radiopharmaceuticals Are Showing Promise as the Next Generation of Cancer Treatment

JT Ripton
Recent major investments signal growth in an emerging therapeutic sector.
Community Oncology Alliance
December 21st 2020

COA Continues Effort to Stop Most Favored Nation Model

Rose McNulty
The Community Oncology Alliance's request includes declarations from community oncology practices detailing the anticipated ramifications should the Most Favored Nation rule become operative.
Kashyap Patel
December 15th 2020

Kashyap Patel, MD, Elected President of Community Oncology Alliance

Rose McNulty
Kashyap Patel, MD, associate editor of Evidence-Based Oncology, a publication of The American Journal of Managed Care, will serve a 1-year term beginning in January.
Basit Chaudhry, MD, PhD, Tuple Health
December 14th 2020

Dr Basit Chaudhry: How Practices Can Take Advantage of the Delay to Oncology Care First

With the start of Oncology Care First (OCF) being delayed, practices participating in the Oncology Care Model have more time to set themselves up to success when they transition to OCF, said Basit Chaudhry, MD, PhD, founder of Tuple Health.
<1
...
141516171819202122
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo